Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study

被引：6

作者：

Shady, Nourhan Hisham ^{[1
]}

Hayallah, Alaa M. ^{[2
,3
]}

Mohamed, Mamdouh F. A. ^{[4
]}

Ghoneim, Mohammed M. ^{[5
,6
]}

Chilingaryan, Garri ^{[7
,8
]}

Al-Sanea, Mohammad M. ^{[9
]}

Fouad, Mostafa A. ^{[10
]}

Kamel, Mohamed Salah ^{[1
,10
]}

Abdelmohsen, Usama Ramadan ^{[1
,10
]}

机构：

[1] Deraya Univ, Fac Pharm, Dept Pharmacognosy, New Minia City 61111, Egypt

[2] Assiut Univ, Fac Pharm, Dept Pharmaceut Organ Chem, Assiut 71526, Egypt

[3] Sphinx Univ, Fac Pharm, Pharmaceut Chem Dept, New Assiut 71515, Egypt

[4] Sohag Univ, Fac Pharm, Dept Pharmaceut Chem, Sohag 82524, Egypt

[5] AlMaarefa Univ, Coll Pharm, Dept Pharm Practice, Ad Diriyah 13713, Saudi Arabia

[6] Al Azhar Univ, Fac Pharm, Dept Pharmacognosy, Cairo 11371, Egypt

[7] NAS RA, Inst Mol Biol, Yerevan 0014, Armenia

[8] Russian Armenian Univ, Inst Biomed & Pharm, Yerevan 0051, Armenia

[9] Jouf Univ, Coll Pharm, Dept Pharmaceut Chem, Aljouf 72341, Saudi Arabia

[10] Minia Univ, Fac Pharm, Dept Pharmacognosy, Al Minya 61519, Egypt

来源：

MOLECULES | 2021年 / 26卷 / 12期

关键词：

COVID-19; coronavirus; molecular docking; Amphimedon sp; sponge; ANTICANCER ACTIVITY; NATURAL-PRODUCTS; INHIBITORS; DESIGN; PROTEASE;

D O I：

10.3390/molecules26123775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Since December 2019, novel coronavirus disease 2019 (COVID-19) pandemic has caused tremendous economic loss and serious health problems worldwide. In this study, we investigated 14 natural compounds isolated from Amphimedon sp. via a molecular docking study, to examine their ability to act as anti-COVID-19 agents. Moreover, the pharmacokinetic properties of the most promising compounds were studied. The docking study showed that virtually screened compounds were effective against the new coronavirus via dual inhibition of SARS-CoV-2 RdRp and the 3CL main protease. In particular, nakinadine B (1), 20-hepacosenoic acid (11) and amphimedoside C (12) were the most promising compounds, as they demonstrated good interactions with the pockets of both enzymes. Based on the analysis of the molecular docking results, compounds 1 and 12 were selected for molecular dynamics simulation studies. Our results showed Amphimedon sp. to be a rich source for anti-COVID-19 metabolites.

引用

页数：15

共 50 条

[1] Computational study of SARS-CoV-2 3CLpro/RdRp-C60 fullerene complexes binding properties
Hurmach, V.
Platonov, M.
Prylutskyy, Yu.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2021, 50 (SUPPL 1): : 158 - 158
[2] Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations
Grottesi, Alessandro
Besker, Neva
Emerson, Andrew
Manelfi, Candida
Beccari, Andrea R.
Frigerio, Francesco
Lindahl, Erik
Cerchia, Carmen
Talarico, Carmine
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 18
[3] Geraniin as a potential inhibitor of SARS-CoV-2 3CLpro
Yu, Wen-Di
Jin, Qi-Ying
Zeng, Mao-Sen
Liu, Jin-Yuan
Xu, Pei-Ping
NATURAL PRODUCT RESEARCH, 2022, 36 (23) : 6060 - 6063
[4] Protocol for production and purification of SARS-CoV-2 3CLpro
Mazzei, Luca
Greene-Cramer, Rebecca
Bafna, Khushboo
Jovanovic, Aleksandar
De Falco, Anna
Acton, Thomas B.
Royer, Catherine Ann
Ciurli, Stefano
Montelione, Gaetano T.
STAR PROTOCOLS, 2023, 4 (02):
[5] Exploring New Small Molecule Inhibitors for SARS-CoV-2 3CLpro: A Comprehensive Computational Study
Hernandez-Hernandez, Jose Manuel
Avila-Aviles, Rodolfo Daniel
CHEMISTRYSELECT, 2024, 9 (37):
[6] Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations
Mosquera-Yuqui, Francisco
Lopez-Guerra, Nicolas
Moncayo-Palacio, Eduardo A.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (05): : 2010 - 2023
[7] Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
Kuang, Yi
Ma, Xiaodong
Shen, Wenjing
Rao, Qingqing
Yang, Shengxiang
FUTURE SCIENCE OA, 2023, 9 (04):
[8] Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
Jo, Seri
Kim, Suwon
Kim, Dae Yong
Kim, Mi-Sun
Shin, Dong Hae
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 1539 - 1544
[9] Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CLpro
Ma, Ling
Xie, Yongli
Zhu, Mei
Yi, Dongrong
Zhao, Jianyuan
Guo, Saisai
Zhang, Yongxin
Wang, Jing
Li, Quanjie
Wang, Yucheng
Cen, Shan
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
[10] Discovery of Nirmatrelvir Resistance Mutations in SARS-CoV-2 3CLpro: A Computational-Experimental Approach
Havranek, Brandon
Demissie, Robel
Lee, Hyun
Lan, Shuiyun
Zhang, Huanchun
Sarafianos, Stefanos
Ayitou, Anoklase Jean-Luc
Islam, Shahidul M.
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (22) : 7180 - 7188

← 1 2 3 4 5 →